Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.51 EUR -1.56%
Market Cap: 96.3m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

EV/S
Enterprise Value to Sales

0
Current
0
Median
7.5
Industry
Higher than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
0
=
Enterprise Value
95.6m EUR
/
Revenue
0 EUR
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
37.7
2-Years Forward
EV/S
14.9
3-Years Forward
EV/S
13.6

See Also

Discover More